PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 30 filers reported holding PROTARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $907,860 | +16.8% | 290,051 | 0.0% | 0.03% | +22.7% |
| Q4 2022 | $777,337 | -9.5% | 290,051 | 0.0% | 0.02% | -12.0% |
| Q3 2022 | $859,000 | +1.1% | 290,051 | 0.0% | 0.02% | -7.4% |
| Q2 2022 | $850,000 | -56.6% | 290,051 | -24.4% | 0.03% | -30.8% |
| Q1 2022 | $1,960,000 | -65.6% | 383,526 | -54.5% | 0.04% | -11.4% |
| Q4 2021 | $5,692,000 | +95.1% | 843,282 | +100.0% | 0.04% | +4.8% |
| Q3 2021 | $2,918,000 | -64.5% | 421,641 | -50.0% | 0.04% | -20.8% |
| Q2 2021 | $8,214,000 | +23.8% | 843,282 | +100.0% | 0.05% | -36.9% |
| Q1 2021 | $6,637,000 | -55.0% | 421,642 | -30.7% | 0.08% | -46.8% |
| Q4 2020 | $14,733,000 | +43.8% | 608,544 | 0.0% | 0.16% | +5.3% |
| Q3 2020 | $10,242,000 | – | 608,544 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $8,077,883 | 2.42% |
| Privium Fund Management (UK) Ltd | 119,730 | $401,096 | 0.32% |
| Ikarian Capital, LLC | 188,664 | $584,859 | 0.13% |
| Orbimed Advisors | 793,558 | $2,483,837 | 0.05% |
| Boxer Capital, LLC | 209,227 | $655 | 0.03% |
| Perceptive Advisors | 290,051 | $907,860 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $198,400 | 0.01% |
| Baker Brothers Advisors | 199,671 | $624,970 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $59,044 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 35,745 | $111,882 | 0.00% |